-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Amphastar Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from 2012 to 2023.
- Amphastar Pharmaceuticals, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $87.2M, a 19.5% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $323M, a 22.1% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. annual Cost of Revenue for 2023 was $293M, a 17.3% increase from 2022.
- Amphastar Pharmaceuticals, Inc. annual Cost of Revenue for 2022 was $250M, a 5.08% increase from 2021.
- Amphastar Pharmaceuticals, Inc. annual Cost of Revenue for 2021 was $238M, a 15.3% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)